Jean-Pierre Delatinne

Title: The Innovations of Jean-Pierre Delatinne

Introduction

Jean-Pierre Delatinne is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of medicine through his innovative patents. With a total of two patents to his name, Delatinne's work focuses on the development of selective inhibitors for various medical conditions.

Latest Patents

Delatinne's latest patents include "Crystalline forms of seletalisib" and "Process for the preparation of nitrogen substituted aminotetralins derivatives." The first patent describes crystalline forms of seletalisib, which are selective inhibitors of PI3 kinase enzymes, particularly beneficial in treating inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, or ophthalmic conditions. The second patent provides an alternative synthesis of N-substituted aminotetralines, enhancing the resolution of these compounds for further applications.

Career Highlights

Throughout his career, Jean-Pierre Delatinne has worked with prominent companies such as UCB Biopharma and UCB Pharma. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Delatinne has collaborated with notable professionals in his field, including Nicolas Edmond Carly and Luc Lambert Jozef Jan Aerts. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Jean-Pierre Delatinne's contributions to the field of medicine through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to influence the development of treatments for various medical conditions.